Investor Presentaiton

Kwality at a Glance: Overview Company overview • 1 About Financial overview 456 ■Sales (Crs) 500 450 ✓ Established in 1983, Kwality Pharmaceuticals is a leading exporter of 400 complex generics formulations with Injectables forming over 70% of its FY 22 sales. 350 300 ✓ Listed on the Bombay Stock Exchange (SME Segment) in 2015 and is migrating to (Main Board) in the coming months. 250 200 150 ✓ Presence in 60+ countries, with 120+ overseas channel partners 100 166 139 ✓ Team size: ~1500 members 50 0 اس 262 Portfolio: 3000+ formulations in >25 therapeutic areas FY 19 FY 20 FY 21 FY 22 ✓ Generic Liquid injectables: Small volume parenteral in vials and ampoules, dental cartridge, ophthalmic, and prefilled syringes. Generic Lyophilized injectables in vials ✓ Others- Oral Liquids, tablets, capsules, dry syrups, and sachets ✓ Oncology liquid and lyophilized Injectables, Oral tablets & capsules ✓ Cephalosporins: Tablets, capsules, dry syrups and sachets, Dry powder injectables Key financial ratios (FY22) ROE 66% RevenueCAGR (FY19-22)-40% Beta-lactam - Oral tablets, capsules, dry syrups, and sachets, Dry powder injectables Gross Margin EBITDA 56% 38.4% Manufacturing: Facilities located in Amritsar (Punjab) and Jassur (Himachal Pradesh) 4

View entire presentation